Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group.
Marcq G, Afferi L, Neuzillet Y, Nykopp T, Voskuilen CS, Furrer MA, Kassouf W, Aziz A, Bajeot AS, Alvarez-Maestro M, Black P, Roupret M, Noon AP, Seiler R, Hendricksen K, Roumiguie M, Pang KH, Laine-Caroff P, Xylinas E, Ploussard G, Moschini M, Sargos P; YAU Urothelial Group. Marcq G, et al. Among authors: black p. Cancers (Basel). 2022 Nov 22;14(23):5740. doi: 10.3390/cancers14235740. Cancers (Basel). 2022. PMID: 36497222 Free PMC article.
Demographic analysis of randomized controlled trials in bladder cancer.
Bachir BG, Shariat SF, Zlotta A, Svatek R, Black PC, Shah JB, Kassouf W; Bladder Cancer Think Tank (Bladder Cancer Advocacy Network); Canadian Bladder Cancer Network (Bladder Cancer Canada). Bachir BG, et al. BJU Int. 2013 Mar;111(3):419-26. doi: 10.1111/j.1464-410X.2012.11401.x. Epub 2012 Aug 29. BJU Int. 2013. PMID: 22928764 Review.
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K, Kikuchi E, Klatte T, Boorjian SA, Lotan Y, Roghmann F, Fairey AS, Fradet Y, Black PC, Rendon R, Izawa J, Kassouf W. Ploussard G, et al. Eur Urol. 2014 Aug;66(2):361-70. doi: 10.1016/j.eururo.2013.09.050. Epub 2013 Oct 9. Eur Urol. 2014. PMID: 24139235
Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non-muscle-invasive bladder cancer.
Bachir BG, Dragomir A, Aprikian AG, Tanguay S, Fairey A, Kulkarni GS, Breau RH, Black PC, Kassouf W. Bachir BG, et al. Cancer. 2014 Aug 15;120(16):2424-31. doi: 10.1002/cncr.28731. Epub 2014 Apr 18. Cancer. 2014. PMID: 24752448 Free article. Clinical Trial.
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
Lucca I, Kassouf W, Kapoor A, Fairey A, Rendon RA, Izawa JI, Black PC, Fajkovic H, Seitz C, Remzi M, Nyirády P, Rouprêt M, Margulis V, Lotan Y, de Martino M, Hofbauer SL, Karakiewicz PI, Briganti A, Novara G, Shariat SF, Klatte T. Lucca I, et al. Among authors: black pc. BJU Int. 2015 Jul;116(1):72-8. doi: 10.1111/bju.12801. Epub 2015 Mar 6. BJU Int. 2015. PMID: 24825476
Conditional survival after radical nephroureterectomy for upper tract carcinoma.
Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Rouprêt M, Matsumoto K, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W. Ploussard G, et al. Eur Urol. 2015 Apr;67(4):803-12. doi: 10.1016/j.eururo.2014.08.003. Epub 2014 Aug 19. Eur Urol. 2015. PMID: 25145551
1,917 results